A federal judge on Friday dismissed a lawsuit by U.S. securities regulators accusing an online entrepreneur of raising more ...

About Fabhalta® (iptacopan) Fabhalta (iptacopan) is an oral, Factor B inhibitor of the alternative complement pathway 6-7.

The U.S. Securities & Exchange Commission sounded the alarm about aspects of the first broad private credit market ...

U.S. President Donald Trump was sued on Friday by the Democratic Party over a recent executive order it says violates federal ...

Bally’s plan to raise $250 million for its Chicago casino from women and minority investors is in regulatory limbo. Bally’s ...

The SEC accuses Bartlesville’s Anthem Blanchard of faking contracts and inflating revenue to defraud investors of over $5 million. No trial date set.

The Securities and Exchange Commission issued guidance on Thursday saying it does not view most meme coins, which are crypto ...

Going case by case, regulators have halted investigations and withdrawn or paused lawsuits against top crypto companies and ...

United States Securities and Exchange Commission (SEC) commissioner Caroline Crenshaw disagrees with the SEC's recent ...

The SEC has once again delayed deciding on whether or not to let Cboe Exchange to list options tied to Ether ETFs.

Donald Trump was sued on Friday by the Democratic Party over a recent executive order it says violates federal election law ...

The Consumer Finance Protection Bureau has dropped several enforcement actions against companies like Capital One and Rocket ...